Erratum: The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics (European Respiratory Journal (2001) vol. 18 (254-261))

M. Solèr, J. Matz, R. Townley, R. Buhl, J. O'Brien, H. Fox, J. Thirlwell, N. Gupta, G. Della Cioppa

Research output: Contribution to journalComment/debate

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)739-740
Number of pages2
JournalEuropean Respiratory Journal
Volume18
Issue number4
StatePublished - Jan 1 2001

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Solèr, M., Matz, J., Townley, R., Buhl, R., O'Brien, J., Fox, H., Thirlwell, J., Gupta, N., & Della Cioppa, G. (2001). Erratum: The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics (European Respiratory Journal (2001) vol. 18 (254-261)). European Respiratory Journal, 18(4), 739-740.